-
Je něco špatně v tomto záznamu ?
Effects of cytochrome P450 inhibitors on peroxidase activity
M. Martinkova, B. Kubickova, M. Stiborova,
Jazyk angličtina Země Švédsko
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
- MeSH
- aktivace enzymů účinky léků MeSH
- benzoflavony chemie farmakologie MeSH
- chinidin chemie farmakologie MeSH
- disulfiram chemie farmakologie MeSH
- dithiokarb chemie farmakologie MeSH
- elipticiny chemie farmakologie MeSH
- inhibitory cytochromu P450 MeSH
- inhibitory enzymů chemie farmakologie MeSH
- ketokonazol chemie farmakologie MeSH
- křenová peroxidasa antagonisté a inhibitory metabolismus MeSH
- lidé MeSH
- metyrapon chemie farmakologie MeSH
- piperonylbutoxid chemie farmakologie MeSH
- proadifen chemie farmakologie MeSH
- substrátová specifita účinky léků MeSH
- sulfafenazol chemie farmakologie MeSH
- systém (enzymů) cytochromů P-450 MeSH
- triazoly chemie farmakologie MeSH
- troleandomycin chemie farmakologie MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
OBJECTIVES: Of several enzymes metabolizing xenobiotics, cytochrome P450 (CYP) and peroxidase enzymes seem to be most important. One of the major challenges in studies investigating metabolism of xenobiotics is to resolve which of these two groups of enzymes is predominant to metabolize individual xenobiotic compounds. Utilization of selective inhibitors of CYP and peroxidase enzymes might be a useful tool to identify the contribution of these enzymes to metabolism of xenobiotics in samples, where both types of enzymes are present. The aim of this study was to investigate specificities of several known CYP inhibitors to these enzymes; whether they inhibit only the CYP enzymes and do not inhibit peroxidases. METHODS: Since the oxidation of o-anisidine catalyzed by a model peroxidase used, horseradish peroxidase (HRP), is a two-substrate reaction, the inhibition potential of tested chemicals was studied with respect to both peroxidase substrates, o-anisidine and hydrogen peroxide. Initial velocities of o-anisidine oxidation by HRP under various conditions were determined spectrophotometrically. RESULTS: The CYP inhibitors metyrapone, troleandomycine, disulfiram, sulfaphenazole, quinidine and 1-aminobenzotriazole do not inhibit o-anisidine oxidation catalyzed by HRP. In contrast, ketoconazole, diethyldithiocarbamate, ellipticine, α-naphtoflavone, proadifen SKF525A, piperonylbutoxide, were found to inhibit not only the CYPs, but also the HRP-mediated oxidation of o-anisidine. Interestingly, α-naphtoflavone inhibits oxidation of o-anisidine by HRP with respect to H2O2, but not with respect to o-anisidine. Diethyldithiocarbamate is the most potent peroxidase inhibitor of o-anisidine oxidation with Ki with respect to o-anisidine of 10 μM and Ki with respect to H2O2 of 60 μM, being even the better peroxidase inhibitor than the classical "peroxidase inhibitor" - propyl gallate (Ki with respect to o-anisidine of 60 μM and Ki with respect to H2O2 of 750 μM). CONCLUSIONS: The results of the present study demonstrate that 1-aminobenzotriazole, a potent inhibitor of various CYP enzymes, seems to be the best candidate suitable for utilization in studies evaluating participation of CYP enzymes in metabolism of xenobiotics in various complex biological materials containing both CYP and peroxidase enzymes. Moreover, precaution to prevent misinterpretation of results is necessary in cases when proadifen SKF525A, piperonylbutoxide, diethyldithiocarbamate, ketoconazole, α-naphtoflavone and ellipticine are used in similar studies (as CYP inhibitors in various complex biological materials containing both CYP and peroxidase enzymes), since these chemicals can except of CYP enzymes inhibit also peroxidase-mediated reactions.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13024004
- 003
- CZ-PrNML
- 005
- 20131002123056.0
- 007
- ta
- 008
- 130703s2012 sw f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)23353841
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Martinkova, Marketa $u Department of Biochemistry, Charles University, Prague, Czech Republic.
- 245 10
- $a Effects of cytochrome P450 inhibitors on peroxidase activity / $c M. Martinkova, B. Kubickova, M. Stiborova,
- 520 9_
- $a OBJECTIVES: Of several enzymes metabolizing xenobiotics, cytochrome P450 (CYP) and peroxidase enzymes seem to be most important. One of the major challenges in studies investigating metabolism of xenobiotics is to resolve which of these two groups of enzymes is predominant to metabolize individual xenobiotic compounds. Utilization of selective inhibitors of CYP and peroxidase enzymes might be a useful tool to identify the contribution of these enzymes to metabolism of xenobiotics in samples, where both types of enzymes are present. The aim of this study was to investigate specificities of several known CYP inhibitors to these enzymes; whether they inhibit only the CYP enzymes and do not inhibit peroxidases. METHODS: Since the oxidation of o-anisidine catalyzed by a model peroxidase used, horseradish peroxidase (HRP), is a two-substrate reaction, the inhibition potential of tested chemicals was studied with respect to both peroxidase substrates, o-anisidine and hydrogen peroxide. Initial velocities of o-anisidine oxidation by HRP under various conditions were determined spectrophotometrically. RESULTS: The CYP inhibitors metyrapone, troleandomycine, disulfiram, sulfaphenazole, quinidine and 1-aminobenzotriazole do not inhibit o-anisidine oxidation catalyzed by HRP. In contrast, ketoconazole, diethyldithiocarbamate, ellipticine, α-naphtoflavone, proadifen SKF525A, piperonylbutoxide, were found to inhibit not only the CYPs, but also the HRP-mediated oxidation of o-anisidine. Interestingly, α-naphtoflavone inhibits oxidation of o-anisidine by HRP with respect to H2O2, but not with respect to o-anisidine. Diethyldithiocarbamate is the most potent peroxidase inhibitor of o-anisidine oxidation with Ki with respect to o-anisidine of 10 μM and Ki with respect to H2O2 of 60 μM, being even the better peroxidase inhibitor than the classical "peroxidase inhibitor" - propyl gallate (Ki with respect to o-anisidine of 60 μM and Ki with respect to H2O2 of 750 μM). CONCLUSIONS: The results of the present study demonstrate that 1-aminobenzotriazole, a potent inhibitor of various CYP enzymes, seems to be the best candidate suitable for utilization in studies evaluating participation of CYP enzymes in metabolism of xenobiotics in various complex biological materials containing both CYP and peroxidase enzymes. Moreover, precaution to prevent misinterpretation of results is necessary in cases when proadifen SKF525A, piperonylbutoxide, diethyldithiocarbamate, ketoconazole, α-naphtoflavone and ellipticine are used in similar studies (as CYP inhibitors in various complex biological materials containing both CYP and peroxidase enzymes), since these chemicals can except of CYP enzymes inhibit also peroxidase-mediated reactions.
- 650 _2
- $a benzoflavony $x chemie $x farmakologie $7 D001571
- 650 _2
- $a systém (enzymů) cytochromů P-450 $7 D003577
- 650 _2
- $a disulfiram $x chemie $x farmakologie $7 D004221
- 650 _2
- $a dithiokarb $x chemie $x farmakologie $7 D004050
- 650 _2
- $a elipticiny $x chemie $x farmakologie $7 D004611
- 650 _2
- $a aktivace enzymů $x účinky léků $7 D004789
- 650 _2
- $a inhibitory enzymů $x chemie $x farmakologie $7 D004791
- 650 _2
- $a křenová peroxidasa $x antagonisté a inhibitory $x metabolismus $7 D006735
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ketokonazol $x chemie $x farmakologie $7 D007654
- 650 _2
- $a metyrapon $x chemie $x farmakologie $7 D008797
- 650 _2
- $a piperonylbutoxid $x chemie $x farmakologie $7 D010882
- 650 _2
- $a proadifen $x chemie $x farmakologie $7 D011335
- 650 _2
- $a chinidin $x chemie $x farmakologie $7 D011802
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a substrátová specifita $x účinky léků $7 D013379
- 650 _2
- $a sulfafenazol $x chemie $x farmakologie $7 D013426
- 650 _2
- $a triazoly $x chemie $x farmakologie $7 D014230
- 650 _2
- $a troleandomycin $x chemie $x farmakologie $7 D014217
- 650 _2
- $a inhibitory cytochromu P450 $7 D065607
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kubickova, Bozena $u -
- 700 1_
- $a Stiborova, Marie $u -
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 33 Suppl 3(2012), s. 33-40
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23353841 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20131002123613 $b ABA008
- 999 __
- $a ok $b bmc $g 987684 $s 822384
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 33 Suppl 3 $d 33-40 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20130703